Aquestive Therapeutics (AQST) Other Non-Current Assets (2017 - 2026)

Aquestive Therapeutics' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets fell 37.49% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at $2.6 million (down 37.49% YoY), while the FY2025 annual figure was $2.6 million, down 37.44% from the prior year.
• Other Non-Current Assets was $2.6 million for Q1 2026 at Aquestive Therapeutics, roughly flat from $2.6 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $6.9 million in Q1 2022 to a low of $2.6 million in Q1 2026.
• Historically, Other Non-Current Assets has averaged $4.8 million across 5 years, with a median of $5.4 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Other Non-Current Assets slipped 5.82% in 2023, then tumbled 37.49% in 2026.
• A 5-year view of Other Non-Current Assets shows it stood at $6.5 million in 2022, then fell by 15.7% to $5.4 million in 2023, then dropped by 22.34% to $4.2 million in 2024, then tumbled by 37.44% to $2.6 million in 2025, then fell by 0.26% to $2.6 million in 2026.
• The last three Other Non-Current Assets figures came in at $2.6 million (Q1 2026), $2.6 million (Q4 2025), and $3.2 million (Q3 2025), per Business Quant data.